Cetirizine

Verify with FDA CVM →

405 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
405
Total Reports
17
Deaths Reported
420.0%
Death Rate

Active Ingredients

Cetirizine

Administration Routes

OralUnknownTopicalAuricular (Otic)Ophthalmic

Species Affected

Dog 358
Cat 28
Human 19

Most Affected Breeds

Retriever - Labrador 40
Shih Tzu 23
Unknown 19
Retriever - Golden 18
Domestic Shorthair 16
Crossbred Canine/dog 15
Pit Bull 13
Maltese 11
Chihuahua 11
Terrier - Yorkshire 11

Most Reported Reactions

Emesis 77
Vomiting 58
Diarrhoea 57
Lethargy (see also Central nervous system depression in 'Neurological') 50
Lack of efficacy - NOS 46
Other abnormal test result NOS 25
Anorexia 22
Decreased appetite 20
Behavioural disorder NOS 19
Pruritus 19
Lethargy (see also Central nervous system depression in Neurological) 19
Lack of efficacy (ectoparasite) - flea 18

Outcome Breakdown

Recovered/Normal
175 (43.2%)
Outcome Unknown
113 (27.9%)
Ongoing
86 (21.2%)
Recovered with Sequela
14 (3.5%)
Euthanized
12 (3.0%)
Died
5 (1.2%)

Data Summary

Metric Value
Total adverse event reports 405
Reports involving death 17
Case-fatality rate (reported events) 420.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cetirizine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 405 adverse event reports referencing Cetirizine, including 17 reports in which the animal died — a 420.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cetirizine. Reported administration routes include Oral, Unknown, Topical, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cetirizine reports are Dog (358 reports), Cat (28 reports), Human (19 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (40), Shih Tzu (23), Unknown (19) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cetirizine are Emesis (77), Vomiting (58), Diarrhoea (57), Lethargy (see also Central nervous system depression in 'Neurological') (50). Of the 405 reports with a coded outcome, Recovered/Normal is the leading category at 43.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cetirizine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial